Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Financings In Brief

This article was originally published in The Gray Sheet

Executive Summary

InTouch Health: Santa Barbara, Calif.-based firm will use proceeds from a $12.1 mil. Series C financing for ongoing product development and expansion of its sales and marketing team. The firm recently launched its RP-7 remote presence robotic system. The funding was led by Galen Partners, which will contribute two board members, as well as existing investors Acacia Venture Partners and InvestCare Partners. InTouch founder Yulan Wang previously founded robotics company Computer Motion, which merged with Intuitive Surgical in 2003...

You may also be interested in...

Pre-Holiday Savings: Device Firms Prepare For Repatriation Tax Bonanza

Johnson & Johnson intends to "repatriate" as much as $10 bil. held by foreign subsidiaries following President Bush's Oct. 22 signing of the "JOBS" bill into law

MIT Spin-Off Evaluates Vascular Drug Delivery With $500,000 In VC Funds

Pervasis Therapeutics will rely in part on seed money from two Boston venture capital firms to help commercialize a vascular drug delivery device that would promote tissue healing

French OTC Industry Frustrated By Regulatory Clampdown in 2019

Speaking exclusively to HBW Insight, French OTC association Afipa reflects on a difficult 2019 which saw tighter restrictions introduced on the sale of popular consumer health products. The trade group believes the industry's best prospects for a brighter future are rebuilding relations with national drug regulator ANSM and to getting self-care higher up the agenda of the French government.



Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts